This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Ghent. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: Bruno Goddeeris: Innovator in Mucosal Membrane Receptor Research
Introduction
Bruno Goddeeris is a notable inventor based in Merelbeke, Belgium. He has made significant contributions to the field of immunology, particularly in the area of mucosal membrane receptors. With a total of 2 patents, his work focuses on advancing our understanding of immune responses and therapeutic applications.
Latest Patents
One of Bruno Goddeeris's latest patents is titled "Mucosal membrane receptor and uses thereof." This invention is centered around the identification of aminopeptidase N (APN) as the receptor for F4 fimbriae of enterotoxigenic E. coli (ETEC). The invention highlights that oral administration of F4 fimbriae can induce a protective intestinal mucosal immune response against subsequent challenges with F4 ETEC. It also notes that the internalization of F4 fimbriae is clathrin-mediated. The patent provides a characterization of APN as a target useful in various applications, including in vitro assays to screen for molecules that can mimic clathrin-mediated F4 endocytosis and modulate the binding of F4 fimbriae with APN. Furthermore, it discusses the development of carriers for delivering antigens or therapeutics to the intestinal submucosa or mucosa-associated lymphoid tissue, which can help induce antigen-specific immune responses and treat bacterial diarrhea.
Career Highlights
Bruno Goddeeris is affiliated with the University of Ghent, where he conducts his research and develops his innovative ideas. His work has garnered attention in the scientific community, contributing to advancements in immunology and therapeutic strategies.
Collaborations
Bruno collaborates with esteemed colleagues such as Kristien Rasschaert and Eric Cox. Their combined expertise enhances the research efforts and fosters innovation in their respective fields.
Conclusion
Bruno Goddeeris is a prominent inventor whose work on mucosal membrane receptors has the potential to significantly impact immunology and therapeutic development. His contributions continue to pave the way for advancements in understanding immune responses and developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
